Found: 14
Select item for more details and to access through your institution.
Tie2-mediated vascular remodeling by ferritin-based protein C nanoparticles confers antitumor and anti-metastatic activities.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00952-9
- By:
- Publication type:
- Article
Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.785981
- By:
- Publication type:
- Article
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 7, p. 629, doi. 10.1007/s12272-023-01454-1
- By:
- Publication type:
- Article
Pathological angiogenesis and inflammation in tissues.
- Published in:
- Archives of Pharmacal Research, 2021, v. 44, n. 1, p. 1, doi. 10.1007/s12272-020-01287-2
- By:
- Publication type:
- Article
Ascochlorin suppresses TGF-β1-induced PAI-1 expression through the inhibition of phospho-EGFR in rat kidney fibroblast cells.
- Published in:
- Molecular Biology Reports, 2012, v. 39, n. 4, p. 4597, doi. 10.1007/s11033-011-1251-y
- By:
- Publication type:
- Article
EphA2 promotes tumorigenicity of cervical cancer by up‐regulating CDK6.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 6, p. 2967, doi. 10.1111/jcmm.16337
- By:
- Publication type:
- Article
Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
- Published in:
- Journal of Cellular Biochemistry, 2012, v. 113, n. 4, p. 1302, doi. 10.1002/jcb.24001
- By:
- Publication type:
- Article
Selective TBK1/IKKi dual inhibitors with anticancer potency.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 8, p. 1972, doi. 10.1002/ijc.28507
- By:
- Publication type:
- Article
Ascochlorin activates p53 in a manner distinct from DNA damaging agents.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 12, p. 2797, doi. 10.1002/ijc.24259
- By:
- Publication type:
- Article
Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1491, doi. 10.1038/s41416-023-02148-7
- By:
- Publication type:
- Article
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.
- Published in:
- SCIENCE CHINA Life Sciences, 2024, v. 67, n. 7, p. 1413, doi. 10.1007/s11427-023-2460-0
- By:
- Publication type:
- Article
Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 1, p. 117, doi. 10.1007/s13402-022-00737-x
- By:
- Publication type:
- Article
Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02109-z
- By:
- Publication type:
- Article
Fatty Acid–Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3929, doi. 10.2147/OTT.S311792
- By:
- Publication type:
- Article